MYDECINE INNOVATIONS GROUP
Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders. They use a world-class technology and drug development infrastructure, and advances new treatment options in areas of significant unmet need. Founded in 2020, the company is based in Vancouver, British Columbia, Canada.
MYDECINE INNOVATIONS GROUP
Industry:
Biotechnology Life Science Therapeutics
Founded:
2013-09-27
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.mydecineinc.com
Total Employee:
11+
Status:
Active
Contact:
604-687-2038
Email Addresses:
[email protected]
Total Funding:
2.27 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator GoDaddy Email GoDaddy Premium DNS
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-06-10 | NeuroPharm | NeuroPharm acquired by Mydecine Innovations Group | 6 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-24 | Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO |
Official Site Inspections
http://www.mydecineinc.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Mydecine Innovations Group"
Psilocybin and Mdma Drug Development - Mydecine Innovations …
Mydecine Innovations Group—a biotechnology company engineering the next wave of innovative medications and treatment protocols to address addiction and mental health.See details»
Our Company - Mydecine Innovations Group
Mydecine Innovations Group, a publicly traded pre-revenue biopharmaceutical company, launched in early 2020 with collaborators and staff members throughout North America and …See details»
Corporate Information - Mydecine Innovations Group
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.See details»
Mydecine Innovations Group Inc. - Canadian Securities Exchange
Mydecine Innovations Group Inc. is a publicly traded, pre-revenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was founded to …See details»
Mydecine Innovations Group - Crunchbase Company Profile
Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders. They use a world-class technology and drug …See details»
Mydecine Innovations Group Announces Listing on the Canadian …
Mydecine Innovations Group is a publicly traded, pre-revenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was founded to …See details»
Mydecine Innovations Group - LinkedIn
Mydecine Innovations Group™ (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) is a biotechnology company developing innovative first- and second-generation novel therapeutics for the …See details»
Mydecine Provides Company Update; Welcomes New Board …
DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology …See details»
Mydecine Innovations Group Provides Corporate Update
Apr 3, 2023 · With its innovative IP portfolio, groundbreaking research, and unwavering commitment to improving patients’ lives, Mydecine is poised to become a significant partner in …See details»
Mydecine Innovations Group Provides Inaugural Corporate …
Aug 12, 2020 · Through our leadership, we are positioning the Company to make a significant role in the future of psychedelic medicine including but not limited to clinical trials focused on …See details»
Mydecine Innovations Group Provides Corporate Update - Yahoo …
Apr 3, 2023 · Mydecine Innovations Group™ (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is a biotechnology company developing the next generation of innovative medications and …See details»
Mydecine Innovations Group Announces Listing on the
Oct 5, 2023 · Mydecine utilizes cutting-edge artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to …See details»
Mydecine Innovations Group Inc. Announces Restructuring …
May 1, 2024 · VANCOUVER, BC – TheNewswire - (May 1, 2024) Mydecine Innovations Group Inc. (CSE: MYCO) (FSE: 0NFA), (OTC: MYCOF) (AQSE: MYIG) (the “Company” or …See details»
Contact - Mydecine Innovations Group
General Inquiry [email protected] Media Inquiry [email protected] Investor Inquiry [email protected] Human Resources Inquiry [email protected] Legal Inquiry …See details»
Mydecine Provides Q4 2023 Business Update - Yahoo Finance
Oct 26, 2023 · Mydecine Innovations Group is a publicly traded, pre-revenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was …See details»
Mydecine’s Exclusive Dealer Identified as ... - Psychedelic Finance
Feb 8, 2022 · Mydecine Innovations Group™ (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) is a biotechnology company developing innovative first- and-second-generation novel therapeutics …See details»
Mydecine™ Launches World's First Natural ... - Psychedelic Finance
Mydecine InnovationsGroup™ is a publicly traded life sciences parent company with offices in Denver, CO and Vancouver, BC. Mydecine™ is dedicated to the development and production …See details»
Mydecine™ Launches World's First Natural-Sourced cGMP …
DENVER, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine™" or the "Company") is pleased to …See details»
Mydecine™ Launches World's First Natural-Sourced cGMP …
DENVER, Aug. 18, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group, Inc., (OTC:MYCOF) (FSE:0NFA) (“Mydecine™” or the “Company”) is pleased to announce it is the …See details»
Mydecine Innovations Group Receives Notice of ... - Markets Insider
Dec 18, 2023 · Mydecine Innovations Group is a publicly traded, pre-revenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was …See details»